These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37222515)

  • 21. Nelson's syndrome after Cushing's disease in childhood: a continuing problem.
    Thomas CG; Smith AT; Benson M; Griffith J
    Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nelson's syndrome in the paediatric age.
    Forni C; Giovanelli MA
    Childs Brain; 1977; 3(5):309-14. PubMed ID: 902514
    [No Abstract]   [Full Text] [Related]  

  • 23. Cavernous sinus involvement in recurrent Nelson's syndrome.
    Sett PK; Crockard HA; Powell M; Lightman S; Jacobs H
    Acta Neurochir (Wien); 1990; 104(1-2):69-72. PubMed ID: 2386092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nelson's syndrome and spontaneous pituitary tumor infarction.
    Jordan RM; Cook DM; Kendall JW; Kerber CW
    Arch Intern Med; 1979 Mar; 139(3):340-2. PubMed ID: 426579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Nelson's syndrome: observations in fifteen patients.
    Kemink SA; Grotenhuis JA; De Vries J; Pieters GF; Hermus AR; Smals AG
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):45-52. PubMed ID: 11167925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
    Reuss WA; Saeger W; Lüdecke DK
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of patients with Nelson's syndrome.
    Pereira MA; Halpern A; Salgado LR; Mendonça BB; Nery M; Liberman B; Streeten DH; Wajchenberg BL
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):533-9. PubMed ID: 9876353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
    Sonino N; Zielezny M; Fava GA; Fallo F; Boscaro M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2647-52. PubMed ID: 8675592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsurgical treatment of Nelson's syndrome.
    Xing B; Ren Z; Su C; Wang R; Yang Y; Hu Y
    Chin Med J (Engl); 2002 Aug; 115(8):1150-2. PubMed ID: 12215280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary surgery for endocrine disorders.
    Nabarro JD
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):285-98. PubMed ID: 7011598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A fatal course of Nelson syndrome].
    Baumann S; Labhart A; Landolt AM; Müller J
    Schweiz Med Wochenschr; 1988 Oct; 118(41):1487-92. PubMed ID: 3238390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary Cushing's syndrome and Nelson's syndrome: diagnostic criteria, surgical therapy, and results.
    Guthrie FW; Ciric I; Hayashida S; Kerr WD; Murphy ED
    Surg Neurol; 1981 Nov; 16(5):316-23. PubMed ID: 6278664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.
    Mirallas O; Filippi-Arriaga F; Hernandez Hernandez I; Aubanell A; Chaachou A; Garcia-Alvarez A; Hernando J; Martínez-Saez E; Biagetti B; Capdevila J
    Front Endocrinol (Lausanne); 2021; 12():731631. PubMed ID: 34858324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nelson's syndrome: case report and review of the literature.
    Ullrich I; Lizarralde G
    South Med J; 1977 Dec; 70(12):1444-6. PubMed ID: 202034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of various neuropeptides on the secretion of proopiomelanocortin-derived peptides by a cultured pituitary adenoma causing Nelson's syndrome.
    Shibasaki T; Masui H
    J Clin Endocrinol Metab; 1982 Nov; 55(5):872-6. PubMed ID: 6126487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nelson's syndrome.
    Barber TM; Adams E; Ansorge O; Byrne JV; Karavitaki N; Wass JA
    Eur J Endocrinol; 2010 Oct; 163(4):495-507. PubMed ID: 20668020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
    Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
    Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nelson's syndrome: incidence and prognosis.
    Kasperlik-Załuska AA; Nielubowicz J; Wisławski J; Hartwig W; Załuska J; Jeske W; Migdalska B
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):693-8. PubMed ID: 6317234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.